The V1/V2 loop of HIV-1 gp120 is necessary for Tat binding and consequent modulation of virus entry

FEBS Letters

Volumn 587, Issue 18, 2013, Pages 2943-2951

  Cardaci, Sabrina ^a,b   Soster, Marco ^a,b   Bussolino, Federico ^a,b   Marchiò, Serena ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

Author keywords

gp120; HIV 1; Peptide; Tat; Virus entry

Indexed keywords

CYSTEINE; GLYCOPROTEIN GP 120; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR MODEL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY;

GP120; HIV-1; PEPTIDE; TAT; VIRUS ENTRY;

AMINO ACID MOTIFS; BINDING SITES; BINDING, COMPETITIVE; CELL LINE; GENE EXPRESSION; GENE PRODUCTS, TAT; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84883488052     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.07.039     Document Type: Article

References (41)

1. A.G. Dalgleish, P.C. Beverley, P.R. Clapham, D.H. Crawford, M.F. Greaves, and R.A. Weiss The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus Nature 312 1984 763 767
2. D. Klatzmann, E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J.C. Gluckman, and L. Montagnier T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV Nature 312 1984 767 768
3. P.J. Maddon, A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss, and R. Axel The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain Cell 47 1986 333 348
4. H. Deng Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661 666
5. T. Dragic HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 Nature 381 1996 667 673
6. Y. Feng, C.C. Broder, P.E. Kennedy, and E.A. Berger HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 1996 872 877
7. E.O. Freed, D.J. Myers, and R. Risser Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41 Proc. Natl. Acad. Sci. USA 87 1990 4650 4654
8. F. Gonzalez-Scarano, M.N. Waxham, A.M. Ross, and J.A. Hoxie Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins AIDS Res. Hum. Retroviruses 3 1987 245 252
9. T. Matthews, M. Salgo, M. Greenberg, J. Chung, R. DeMasi, and D. Bolognesi Enfuvirtide: the first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes Nat. Rev. Drug Disc. 3 2004 215 225
10. G. Fatkenheuer Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection N. Engl. J. Med. 359 2008 1442 1455
11. W.G. Nichols, H.M. Steel, T. Bonny, K. Adkison, L. Curtis, J. Millard, K. Kabeya, and N. Clumeck Hepatotoxicity observed in clinical trials of aplaviroc (GW873140) Antimicrob. Agents Chemother. 52 2008 858 865
12. J. Lalezari Safety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects J. Acquir. Immune Defic. Syndr. 57 2011 118 125
13. R.E. Nettles Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects J. Infect. Dis. 206 2012 1002 1011
14. C.J. Bruno, and J.M. Jacobson Ibalizumab: an anti-CD4 monoclonal antibody for the treatment of HIV-1 infection J Antimicrob. Chemother. 65 2010 1839 1841
15. S. Marchiò Cell surface-associated Tat modulates HIV-1 infection and spreading through a specific interaction with gp120 viral envelope protein Blood 105 2005 2802 2811
16. S.K. Arya, C. Guo, S.F. Josephs, and F. Wong-Staal trans-Activator gene of human T-lymphotropic virus type III (HTLV-III) Science 229 1985 69 73
17. H.K. Chang, R.C. Gallo, and B. Ensoli Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat Protein J. Biomed. Sci. 2 1995 189 202
18. A. Albini HIV-1 Tat protein mimicry of chemokines Proc. Natl. Acad. Sci. USA 95 1998 13153 13158
19. B. Ensoli, L. Buonaguro, G. Barillari, V. Fiorelli, R. Gendelman, R.A. Morgan, P. Wingfield, and R.C. Gallo Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation J. Virol. 67 1993 277 287
20. A. Albini, G. Barillari, R. Benelli, R.C. Gallo, and B. Ensoli Angiogenic properties of human immunodeficiency virus type 1 Tat protein Proc. Natl. Acad. Sci. USA 92 1995 4838 4842
21. H.C. Chang, F. Samaniego, B.C. Nair, L. Buonaguro, and B. Ensoli HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region AIDS 11 1997 1421 1431
22. M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 Tat requires cell surface heparan sulfate proteoglycans J. Biol. Chem. 276 2001 3254 3261
23. W.G. Robey, B. Safai, S. Oroszlan, L.O. Arthur, M.A. Gonda, R.C. Gallo, and P.J. Fischinger Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients Science 228 1985 593 595
24. B.R. Starcich Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS Cell 45 1986 637 648
25. C.K. Leonard, M.W. Spellman, L. Riddle, R.J. Harris, J.N. Thomas, and T.J. Gregory Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells J. Biol. Chem. 265 1990 10373 10382
26. C. Cheng-Mayer, R. Liu, N.R. Landau, and L. Stamatatos Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor J. Virol. 71 1997 1657 1661
27. M. Kowalski Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 Science 237 1987 1351 1355
28. L. Naldini, U. Blomer, P. Gallay, D. Ory, R. Mulligan, F.H. Gage, I.M. Verma, and D. Trono In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector Science 272 1996 263 267
29. T. Dull, R. Zufferey, M. Kelly, R.J. Mandel, M. Nguyen, D. Trono, and L. Naldini A third-generation lentivirus vector with a conditional packaging system J. Virol. 72 1998 8463 8471
30. M.S. Malnati, G. Scarlatti, F. Gatto, F. Salvatori, G. Cassina, T. Rutigliano, R. Volpi, and P. Lusso A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load Nat. Protoc. 3 2008 1240 1248
31. J. Weidner, U. Cassens, W. Gohde, W. Sibrowski, G. Odaibo, D. Olaleye, D. Reichelt, and B. Greve An improved PCR method for detection of HIV-1 proviral DNA of a wide range of subtypes and recombinant forms circulating globally J. Virol. Met. 172 2011 22 26
32. S. Mitola, R. Soldi, I. Zanon, L. Barra, M.I. Gutierrez, B. Berkhout, M. Giacca, and F. Bussolino Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells J. Virol. 74 2000 344 353
33. R. Wyatt, J. Moore, M. Accola, E. Desjardin, J. Robinson, and J. Sodroski Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding J. Virol. 69 1995 5723 5733
34. J. Cao, N. Sullivan, E. Desjardin, C. Parolin, J. Robinson, R. Wyatt, and J. Sodroski Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein J. Virol. 71 1997 9808 9812
35. L. Stamatatos, M. Wiskerchen, and C. Cheng-Mayer Effect of major deletions in the V1 and V2 loops of a macrophage-tropic HIV type 1 isolate on viral envelope structure, cell entry, and replication AIDS Res. Hum. Retroviruses 14 1998 1129 1139
36. E. Mbemba, A. Benjouad, L. Saffar, and L. Gattegno Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells Virology 265 1999 354 364
37. R.R. Vives, A. Imberty, Q.J. Sattentau, and H. Lortat-Jacob Heparan sulfate targets the HIV-1 envelope glycoprotein gp120 coreceptor binding site J. Biol. Chem. 280 2005 21353 21357
38. E. Crublet, J.P. Andrieu, R.R. Vives, and H. Lortat-Jacob The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site J. Biol. Chem. 283 2008 15193 15200
39. F. Nappi Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles J. Gene Med. 11 2009 955 965
40. J.P. Gratton, J. Yu, J.W. Griffith, R.W. Babbitt, R.S. Scotland, R. Hickey, F.J. Giordano, and W.C. Sessa Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo Nat. Med. 9 2003 357 362
41. P. Monini HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies PLoS One 7 2012 e48781